Clinical Trial Update: Efficacy and Safety of Momelotinib Combined With Trametinib in Adults With Metastatic KRAS-mutated Non-Small Cell Lung Cancer (NSCLC) Who Have Failed Platinum-Based Chemotherapy Preceded by a Dose-finding Lead-in Phase [Phase 1]

View source ↗

Summary

A terminated Phase 1 trial assessing the efficacy and safety of combining momelotinib with trametinib in adults with relapsed/metastatic KRAS-mutated non-small …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Momelotinib (momelotinib)
• Trametinib (trametinib)

Snippet

Sponsor: Sierra Oncology LLC - a GSK company | Conditions: Relapsed Metastatic KRAS-Mutated Non-Small Cell Lung Cancer | Phase 1 | Status: TERMINATED